Dr. Vivek Vij
CURRICULUM VITAE
Kwang-Woong Lee, M.D., Ph.D.
Address(hospital): Department of Surgery
Seoul National University Hospital
101 Daehak-ro, Jongno-gu
Seoul 03080
South Korea
Telephone: +82-2-2072-2511
Fax: +82-2-766-3975
E-mail: kwleegs@, kwleegs@snu.ac.kr
Citizenship: South Korea
Education:
l991 B.S. Seoul National University
2000 M.D. Seoul National University
2002 Ph.D. Seoul National University
Postdoctoral Training:
Internships and Residencies:
l991-l992 Intern
Seoul National University Hospital, Seoul, Korea.
1992-1996 Resident in General Surgery
Seoul National University Hospital, Seoul, Korea.
1996-1999 Military service
Fellowships:
1999-2000 Fellow in Liver Transplantation
Seoul National University Hospital, Seoul, Korea.
2000-2001 Fellow in Transplantation Surgery
Samsung Medical Center, Seoul, Korea.
Appointments:
2001-2005.6 Assistant and Associate Professor of Surgery (Division of Transplantation)
School of Medicine, Sungkyunkwan University, Seoul, Korea
2005.8-2007.8 Visiting Associate Professor of Surgery (Division of Transplantation)
School of Medicine, Johns Hopkins University
2008.1-2010.3 Chief of organ transplantation center, Chief of hepatobiliary research division
National Cancer Center, Goyang-si, Korea.
2010.4-2015.2 Associate professor of Seoul National University Hospital
2015.3-Current Professor of Seoul National University College of Medicine
2014.6-Current Executive Director of International Healthcare Center, SNUH
2016.12-Current Honorary President of Hepatolo-Transplant Association of Kazakhstan
2017.1-Current Visiting Professor, University of Medicine 1, Yangon, the Republic of the Union
of Myanmar
2017.6-Current Chief of division of Hepato-Pancreatico-Biliary surgery, SNUH
2017.6-Current Vice president of SNUH for Global planning and development
2018.6-Current the editorial board of Chirurgia Journal
2018.8-Current Editorial Board of Formosa Journal of Surgery
Brief Introduction
Professor Lee graduated from Seoul National University. He has been with Samsung Medical Center and National Cancer Center, Korea as a hepatic and transplant surgeon. He has also been in Johns Hopkins University Hospital as a LDLT consultant. He is an executive director of international health care center and a professor of department of surgery, Seoul National University, Korea. He performed the first successful hepatocyte transplantation in Korea when he was in Samsung Medical Center. His research topics are hepatocyte transplantation, gene delivery, cancer stem cell, best immunosuppressant for HCC, bile duct ischemia induced by warm ischemia, polymorphism and so on. He developed several innovative techniques to reduce biliary complications after liver transplantation such as high hilar dissection (HHD) and Tailored Telescopic Reconstruction (TTR) of bile duct. He also played an important role to change deceased donor allocation system in Korea (split liver transplantation regulation and Deceased donor allocation system based on MELD) by publishing several important papers analyzing Korean database. He performed first living donor liver transplantation for pure foreign patients in Korea when he was in National Cancer Center, Korea. And he has performed more than 70 cases of LDLT in Kazakhstan, Georgia and Myanmar since 2013.
Licensure and Certification:
1991. Korean Medical License #43728.
1996 Korean Board of Surgery #3680.
2006 ECFMG certificate #6828362.
Membership
Korean Society for Transplantation(Associate chief of scientific committee)
Korean Society of Organ Transplantation
Korean Association of HBP Surgery(Chief of scientific committee)
Korean Surgical Society(Associate chief of scientific committee)
Korean Association for the study of the liver
Korean Liver Cancer Study Group
International Liver Transplantation Society
Scientific Publications: (English paper only)
1. K.S. Suh, K.W. Lee, Y.T. Koh, H.R. Roh, J.K. Chung, K.W. Minn, S.E. Jung, K.W. Park, S.J. Kim and K.U. Lee. 「First Successful in Situ Split-Liver Transplantation in Korea」, Transplantation proceedings, 32(7):2140, 2000.11.
2. K.S. Suh, K.W. Lee, H.R. Roh, M.K. Lee, Y.T. Koh, and K.U. Lee. 「Various Types of Donor Hepatectomy According to the Required Graft Volume in Adult Living Donor Liver Transplantation」, Transplantation proceedings, 33(1-2):1410, 2001.2-3.
3. K.S. Suh, K.W. Lee, H.R. Roh, Y.T. Koh, K.W. Minn, S.J. Kim, M.H. Park and K.U. Lee. 「Outcome of Adult Living Donor Liver Transplantation Using Small Volume of Left Liver Graft Less Than 1% of Body Weight」, Transplantation proceedings, 33(1-2):1401, 2001.2-3.
4. K.W. Lee, S.K. Lee, J.W. Joh, S.J. Kim, J.H. Park, S.E. Chon, S.H. Choi, J.S., S.W. Paik, K.W. Koh, J.H. Lee, M.S. Choi, Y.I. Kim, and B.B. Lee. 「Comparison of the Efficacy in Prevention of Hepatitis B Virus Recurrence After Liver Transplantation Between HBIG and Lamivudine」, Transplantation Proceedings, 33:3643-3644, 2001.12.
5. K.W. Lee, T.S. Son, J.W. Joh, S.J. Kim, J.H. Park, S.E. Chon, S.H. Choi, J.S. Heo, Y.I. Kim, B.B. Lee, and S.K. Lee. 「Perioperative cytokine response after liver transplantation」, Transplantation proceedings, 35(1):407-408, 2003.2
6. K.W. Lee, J.W. Joh, S.J. Kim, J.H. Park, S.E. Chon, S.H. Choi, J.S. Heo, J.H. Song, S.M. Kim, K.R. Peck, Y.I. Kim, B.B. Lee, and S.K. Lee. 「Living donor liver transplantation using graft infested with Clonorchis sinensis: two cases」. Transplantation proceedings. 35(1):66-67, 2003.2
7. J.H. Park, J.H. Noh, K.W. Lee, S.K. Lee, S.J. Kim, S.H. Choi, J.S. Heo, S.E. Chon, S.W. Paik, K.W. Koh, J.H. Lee, M.S. Choi Y.I. Kim, B.B. Lee, and J.W. Joh. 「Safety of the donor with right hepatic lobectomy in the living donor transplantation」. Transplantation proceedings 35(1):57-58, 2003.2
8. W.Y. Lee, K.W. Lee, J.S. Heo, S.H. Choi , S.J. Kim , J.W. Joh, S.K. Lee. 「Prolongation of pig liver perfusion time by gabexate mesilate continuous infusion in extracoporeal perfusion system using bio-pump」. Transplantation proceedings 35(1):128-129, 2003.2
9. S.J. Kim, T.Y. Yang, I.K. Jeong, M.K. Lee, S.W. Choo, K.W. Lee, J.W. Joh, S.K. Lee, B.B. Lee, and K.W. Kim, 「Retransplantation of Islet After Simultaneous Islet-Kidney Transplantation: A Case Report」, Transplantation Proceedings, 35:476-478, 2003.2
10. S.J.Kim, K.W.Lee, S.K.Lee, B.B.Lee, J.W.Joh, Y.G.kim, W.S.Huh, and H.Y.Oh, 「Renal transplantation of hepatitis B virus positive recipients」, Moduzzi Editore 165-168, 2003
11. S.J.Kim, K.W.Lee, S.K.Lee, B.B.Lee, J.W.Joh, Y.G.kim, W.S.Huh, and H.Y.Oh, 「Importance of Cytomegalovirus(CMV) Antigenemia in Kidney Transplantation」, Moduzzi Editore 161-164, 2003
12. SH Park, DY Kim, JS Heo, DH Kim, CK Park, KW Lee, SH Choi, TS Sohn, S Kim, JH Noh, YI Kim, JO Park, K Kim, WS Kim, CW Jung, YH Im, MH Lee, K Park, CH Park & WK Kang, 「Postoperative chemoradiotherapy for gastric cancer」, Annals of Oncology 14:1373-1377, 2003.9
13. J. A. Kim, W. Huh, K. W. Lee, S. J. Kim, Y. -G. Kim, D. J. Kim, J. -W. Joh and H. -Y. Oh, 「Cadaveric renal transplantation in hepatitis B antigen–positive recipients using hepatitis B antigen–positive donor organs with lamivudine treatment」, Transplantation Proceedings, 36(5):1434-1437, 2004.6
14. Doo-Hoon Lee, Hee-Hoon Yoon, Ji-Hyun Lee, Kwang-Woong Lee, Suk-Koo Lee, Sung-Koo Kim, Jung-Eun Choi, Young-Jin Kim and Jung-Keug Park, 「Enhanced liver-specific functions of endothelial cell-covered hepatocyte hetero-spheroids」, Biochemical Engineering Journal 20:181-187, 2004.8
15. KW Lee, SK Lee, JW Joh, SJ Kim, BB Lee, KW Kim, KU Lee, 「Influence of pancreatic islet on spheroid formation and functions of hepatocytes in hepatocyte-pancreatic islet spheroid culture」, Tissue engineering, 10(7/8):965-977. 2004. 07-08
16. KW Lee, DS Lee, HH Lee, JW Joh, SH Choi, JS Heo, SK Lee, SJ Kim, 「Interposition vein graft in living donor liver transplantation (LDLT)」, Transplantation Proceedings 36(8):2261-2262, 2004.10
17. KW Lee, JB Park, JJ Yoon, JH Lee, SY Kim, HJ Jung, SK Lee, SJ Kim, HH Lee, DS Lee, JW Joh, 「The viability and function of cryopreserved hepatocyte spheroids with different cryopreservation solutions」, Transplantation Proceedings 36(8):2462-2463, 2004.10
18. KW Lee, JJ Yoon, JH Lee, SY Kim, HJ Jung, SJ Kim, JW Joh, HH Lee, DS Lee, SK Lee, 「Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosan」, Transplantation Proceedings 36(8):2464-2465, 2004.9
19. KW Lee, SJ Kim, DS Lee, HH Lee, JW Joh, SK Lee, HY Oh, DJ Kim, YG Kim, WS Huh, WI Oh, BB Lee, 「Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation」, Transplantation Proceedings 36(7):2009-2010. 2004. 09
20. KW Lee, HH Lee, DS Lee, SJ Kim, JW Joh, HY Oh, JW Kim, YG Kim, WS Huh, DJ Kim, SK Lee, BB Lee, 「Polymerase chain reaction for the diagnosis of human polyomavirus associated nephropathy in renal transplant recipients」, Transplantation Proceedings 36(7):2116-2117. 2004. 09
21. KW Lee, JW Park, JW Joh, SJ Kim, SH Choi, HH Lee, DS Lee, JH Park, BC Yoo, SW Paik, KC Koh, JH Lee, MS Choi, SK Lee, 「Can we expand milan criteria for hepatocellular carcinoma in living donor liver transplantation?」, Transplantation Proceedings 36(8):2289-2290, 2004.10
22. HH Lee, DS Lee, JH Park, KW Lee, SJ Kim, JW Joh, JM Seo, GY Kwon, YH Choe, SK Lee, 「A case of laryngeal post transplantation lymphoproliferative disease」, Transplantation Proceedings 36(8):2305-2306. 2004.10
23. SH Choi, HH Lee, DS Lee, JH Choi, JS Heo, KW Lee, JW Joh, SJ Kim, BC Yoo, JH Lee, MS Choi, YH Choe, SK Lee, 「Clinicopathologic features of incidental hepatocellular carcinoma in liver transplantation」, Transplantation Proceedings 36(8):2293-2294. 2004.10
24. JS Heo, JW Park, KW Lee, SK Lee, JW Joh, SJ Kim, HH Lee, DS Lee, SH Choi, JM Seo, YH Choe, 「Posttransplant lymphoproliferative disorder(PTLD) in pediatric liver transplantation」, Transplantation Proceedings 36(8):2307-2308. 2004.10
25. HH Lee, DS Lee, KE Yoo, KW Lee, SJ Kim, JW Joh, JM Seo, YH Choe, SK Lee,「Case of living donor liver transplantation in a patient with biliary atresia combined with situs inversus」, Transplantation Proceedings 36(8):2282-2283. 2004.10
26. DS Lee, JK Woo, HH Lee, JW Joh, SJ Kim, SH Choi, JS Heo, WS Hyon, GS Kim, SK Lee, 「Auxiliary partial orthotopic liver transplantation (APOLT) in the treatment of acute liver failure: A case report」, Transplantation Proceedings 36(8):2228-2229. 2004.10
27. KW Lee, JW Joh, SJ Kim, SH Choi, JS Heo, HH Lee, JW Park, SK Lee,「High hilar dissection: new technique to reduce biliary complication in living donor liver transplantation」, Liver Transplantation, 10(9):1158-1162. 2004. 9
28. KW Lee, DS Lee, HH Lee, SJ Kim, JW Joh, JM Seo, YH Choe, SK Lee, 「Prevention of de novo hepatitis B infection from HbcAb positive donors in living donor liver transplantation」, Transplantation Proceedings 36(8):2311-2312, 2004.10
29. SJ Kim, KW Lee, DS Lee, HH Lee, SK Lee, B Kim, WS Huh, HY Oh, and JW Joh, 「Randomized trial of tacrolimus versus cyclosporine in steroid withrawal in living donor renal transplant recipients」, Transplantation Proceedings 36(7):2098-2100, 2004.10
30. SJ Kim, HH Lee, DS Lee, KW Lee, JW Joh, DH Woo, GY Kwon, HY Oh, YG Kim, WS Huh, DJ Kim, GS Kim, SK Lee, BB Lee,「 Prognostic factors affecting graft and patient survival in cadaveric and living kidney transplantation」, Transplantation Proceedings 36(7):2038-2039, 2004.10
31. EZ Lee, EY Kim, J Lee, HJ Lee, KW Lee, JW Joh, SK Lee, DS Lee, HH Lee, and SJ Kim. 「Changes in expression of T-cell activation-related molecules and cytokines during tolerance induction in allogeneic skin transplantation murine model」, Transplantation Proceedings 36(8):2425-2428, 2004.10
32. DS Lee, WH Gil, HH Lee, KW Lee, SK Lee, SJ Kim, SH Choi, JS Heo, WS Hyon, GS Kim, SW Paik, KC Koh and JW Joh, 「Factors affecting graft survival after living donor liver transplantation」, Transplantation Proceedings 36(8):2255-2256. 2004.10
33. H.H. Lee, J.W. Joh, K.W. Lee, S.J. Kim, D.S. Lee, J.H. Park, S.H. Choi, J.S. Heo, W.S. Hyon, M.S. Kwak, and S.K. Lee, 「Small-for-Size Graft in Adult Living-Donor Liver Transplantation」, Transplantation Proceedings 36(8):2274-2276. 2004.10
34. JW Joh, HH Lee, DS Lee, KW Lee, SK Lee, SJ Kim.「The influence of mycophenolate mofetil(MMF) and azathioprine(AZA) on the same cadaveric donor renal transplantation」, Journal of Korean Medical Science 20(1):79-81, 2005.2
35. J Lee, EN Lee, EY Kim, HJ Lee, HJ Park, CL Sun, SK Lee, JW Joh, KW Lee, GY Kwon, and SJ Kim. 「4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD45RB and anti-CD40L monoclonal antibodies」, Transplantation Proceedings 37(1):123-125. 2005.1-2
36. MS Gwak, KW Lee, SH Kim, JH Lee, JW Joh, SJ Kim, HH Lee, JW Park, GS Kim, SK Lee, 「Can a leukocyte depletion filter (LDF) reduce the risk of reintroduction of hepatocellular carcinoma cells?」, Liver Transpl. 2005 Mar;11(3):331-5
37. Hong SN, Lee SY, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC, Rhee JC, Choi D, Lim HK, Lee KW, Joh JW. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol. 2005 Mar;39(3):247-52.
38. Joh JW, Lee HH, Park JW, Lee DH, Yoo BC, Lee KW, Kim SJ. Genotypic resistance of hepatitis B virus to lamivudine in renal transplant recipients. Transplant Proc. 2005 Mar;37(2):1235-7.
39. Lee HH, Joh JW, Park JH, Lee KW, Heo JS, Choi SH, Kim SJ, Lee SK. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma. Transplant Proc. 2005 Mar;37(2):1251-3.
40. Lee J, Lee EN, Kim EY, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Lee KW, Kwon GY, Joh JW, Kim SJ. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease. Immunol Lett. 2005 Nov 15;101(2):210-6.
41. Ki CS, Kim IS, Kim JW, Lee NY, Kim SH, Lee KW, Kim SJ, Joh JW, Huh WS, Oh HY. Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients. Clin Transplant. 2005 Dec;19(6):751-5.
42. Cho JY, Suh KS, Kwon CH, Yi NJ, Lee HH, Park JW, Lee KW, Joh JW, Lee SK, Lee KU. Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Liver Transpl. 2006 Feb;12(2):201-6.
43. Lee KW, Park JW, Park JB, Kim SJ, Choi SH, Heo JS, Kwon CH, Kim DJ, Han YS, Lee SK, Joh JW. Liver transplantation for hepatocellular carcinoma with bile duct thrombi. Transplant Proc. 2006 Sep;38(7):2093-4.
44. Kwon CH, Joh JW, Lee KW, Kim SJ, Han YS, Park JW, Kim DJ, Park JB, Lee SK. Safety of donors with fatty liver in liver transplantation. Transplant Proc. 2006 Sep;38(7):2106-7.
45. Park JW, Lee KW, Kim SJ, Choi SH, Heo JS, Kwon CH, Kim DJ, Han YS, Lee SK, Joh JW. Outcome of patients with recurrent hepatocellular carcinoma in liver transplantation. Transplant Proc. 2006 Sep;38(7):2121-2.
46. Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today. 2006;36(10):892-7
47. Lee KW, Simpkins CE, Montgomery RA, Locke JE, Segev DL, Maley WR. Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation. 2006 Dec 27;82(12):1683-8.
48. Yi NJ, Suh KS, Cho JY, Kwon CH, Lee KW, Joh JW, Lee SK, Kim SI, Lee KU. Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl. 2007 Mar;13(3):451-8.
49. Lee BH, Lee JE, Lee KW, Nam HY, Jeon HJ, Sung YJ, Kim JS, Lim HJ, Park JS, Ko JY, Kim DJ. Coating with paclitaxel improves graft survival in a porcine model of haemodialysis graft stenosis. Nephrol Dial Transplant. 2007 Oct;22(10):2800-4.
50. Lee KW, Lee JH, Shin SW, Kim SJ, Joh JW, Lee DH, Kim JW, Park HY, Lee SY, Lee HH, Park JW, Kim SY, Yoon HH, Jung DH, Choe YH, Lee SK. Hepatocyte transplantation for glycogen storage disease type Ib. Cell Transplant. 2007;16(6):629-37.
51. Han MS, Park SY, Shinzawa K, Kim S, Chung KW, Lee JH, Kwon CH, Lee KW, Lee JH, Park CK, Chung WJ, Hwang JS, Yan JJ, Song DK, Tsujimoto Y, Lee MS. Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes. J Lipid Res. 2008 Jan;49(1):84-97
52. Park JB, Kwon CH, Lee KW, Choi GS, Kim DJ, Seo JM, Kim SJ, Joh JW, Lee SK. Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients. Transpl Int. 2008 Apr;21(4):346-52
53. Lee KW, Cameron AM, Maley WR, Segev DL, Montgomery RA. Factors affecting graft survival after adult/child split liver transplantation: analysis of UNOS/OPTN database. Am J Transplant. 2008 Jun;8(6):1186-96.
54. Kim SH, Cho SY, Park SJ, Lee KW, Han SS, Lee SA, Park JW, Kim CM. Learning curve for living-donor liver transplantation in a fledgling cancer center. Transpl Int. 2009 Dec;22(12):1164-71.
55. Cho SY, Kim SH, Lee KW, Park SJ, Han SS, Kim YK. Ligation of left renal vein as a salvage procedure for splenorenal shunt after living donor liver transplantation: a case report.Transplant Proc. 2009 Dec;41(10):4243-5.
56. Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW. Comparative Analysis between Clinical Outcomes of Primary Radical Resection and Second Completion Radical Resection for T2 Gallbladder Cancer: Single-center Experience. World J Surg. 2010 Mar 24;34(7):1572-8
57. Kim YK, Lee KW, Cho SY, Han SS, Kim SH, Kim SK, Park SJ. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients. Liver Transpl. 2010 Jun;16(6):767-72.
58. Cho SY, Park SJ, Kim SH, Han SS, Kim YK, Lee KW, Lee SA, Hong EK, Lee WJ, Woo SM. Survival Analysis of Intrahepatic Cholangiocarcinoma After Resection. Ann Surg Oncol. 2010 Jul;17(7):1823-30.
59. Cho SY, Kim SH, Park SJ, Han SS, Kim YK, Lee KW, Lee WJ, Woo SM, Kim TH. Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol. 2010 Jul 1;102(1):87-93.
60. Kim SH, Lee KW, Kim YK, Cho SY, Han SS, Park SJ. Tailored telescopic reconstruction of the bile duct in living donor liver transplantation. Liver Transpl. 2010 Sep;16(9):1069-74.
61. Eom BW, Yoon H, Han SS, Ryu KW, Lee JH, Kim SH, Lee KW, Park SJ, Kim YW. Laparoscopy-assisted distal gastrectomy combined with laparoscopic spleen-preserving distal pancreatectomy for the treatment of early gastric cancer with pancreatic cystic neoplasm. J Laparoendosc Adv Surg Tech A. 2010 Sep;20(7):643-7.
62. Kim SH, Kim W, Lee KW, Hong EK, Kim HJ. Tumefactive demyelination, an uncommon form of tacrolimus neurotoxicity. Neurology. 2011 Feb 15;76(7):672-4.
63. Lee KW, Kim SH, Han SS, Kim YK, Cho SY, You T, Park SJ. Use of an upper midline incision for living donor partial hepatectomy: a series of 143 consecutive cases. Liver Transpl. 2011 Aug;17(8):969-75
64. Kim H, Suh KS, Jeon YM, Park MS, Choi Y, Mori S, Hong G, Lee HW, Yi NJ, Lee KW. Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation. Transplant Proc. 2012 Apr;44(3):755-6
65. Lee HW, Lee KW, Kim BW, Song GW, Han YS, Kwon CH, Kim SH, Choi GH, JY Choi. Liver Transplantation for Hepatitis C Virus-Related Liver Disease in Korea. J Korean Soc Transplant 2012 May;26:269-276
66. Lee WH, Yi NJ, Km H, Choi YR, Park MS, Hong G, Choi JY, Chung HH, Lee KW, Park DJ, Mn HS, Chung JK, Suh KS. Metastatic follicular struma ovarii complicating pregnancy 2012.9, 123-127
67. Kim YK, Lee KW, Kim SH, Cho SY, Han SS, Park SJ. Early steroid withdrawal regimen prevents new-onset diabetes mellitus in old-age recipients after living donor liver transplantation. World J Surg. 2012 Oct;36(10):2443-8
68. Lee KW. Hanging maneuver by Glisson's approach before parenchymal dissection in living donor right hepatectomy under the upper midline incision. World J Surg. 2012 Nov;36(11):2746-7
69. Chu HH1, Kim HC, Jae HJ, Yi NJ, Lee KW, Suh KS, Chung JW, Park JH. Percutaneous transsplenic access to the portal vein for management of vascular complication in patients with chronic liver disease. Cardiovasc Intervent Radiol. 2012 Dec;35(6):1388-95.
70. Jung YJ, Kim BG, Kim JS, Kim W, Yoon JH, Lee HS, Yi NJ, Lee KW, Suh KS, Kim
YJ. The effect of pretransplantation lamivudine resistance on the prognosis of
liver transplant recipients. Transplant Proc. 2013 Jan-Feb;45(1):231-5.
71. Kim JM, Kim GS, Joh JW, Suh KS, Park JB, Ko JS, Kwon CH, Yi NJ, Gwak MS, Lee KW,
Kim SJ, Lee SK Long-term results for living donor liver transplant recipients with hepatocell
lar carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int.
2013 Jan;26(1):84-9.
72. Yi NJ, Lee KW, Kong SY, Park KU, Lee KB, Hong G, Han SS, Park SJ, Suh KS.
Outcome of various treatments for posttransplant hepatitis B virus recurrence.
World J Surg. 2013 Apr;37(4):812-9.
73. Jeon YM, Lee KW, Yi NJ, Lee JM, Hong G, Choi Y, Park MS, Kim H, Suh KS. The
right posterior bile duct anatomy of the donor is important in biliary
complications of the recipients after living-donor liver transplantation. Ann
Surg. 2013 Apr;257(4):702-7.
74. Yi NJ, Suh KS, Suh SW, Chang YR, Hong G, Yoo T, Kim H, Park MS, Choi YR, Lee
KW, Jung CW, Lee JH, Kim YJ, Yoon JH, Lee HS. Excellent outcome in 238
consecutive living donor liver transplantations using the right liver graft in a
large volume single center. World J Surg. 2013 Jun;37(6):1419-29.
75. Hong G, Lee KW, Suh S, Yoo T, Kim H, Park MS, Choi Y, Yi NJ, Suh KS. The Model
for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality
Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during
Waiting for Deceased Liver Transplantation. J Korean Med Sci. 2013 Aug;28(8):1207-12
76. Mori S, Kim H, Park MS, Choi Y, Hong G, Yi NJ, Lee KW, Suh KS. Graft regeneration rate
and small-for-size syndrome in living donor liver transplantation. Hepatogastroenterology. 201
3 Sep;60(126):1463-8.
77. Park MS, Lee KW, You T, Suh SW, Kim H, Choi Y, Hong G, Kim OK, Yi NJ, Suh KS
The "ABO Cross-transplantation Problem" in Liver Transplantation in Korea. Transplant Proc. 2013 Oct;45(8):2878-9.
78. Yi NJ, Choi JY, Suh KS, Cho JY, Baik M, Hong G, Lee KW, Kim W, Kim YJ, Yoon JH, Lee HS, Kim DG. Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin. J Gastroenterol. 2013 Dec;48(12):1401-10.
79. Choi Y, Choi JY, Yi NJ, Lee K, Mori S, Hong G, Kim H, Park MS, Yoo T, Suh SW, Lee HW, Lee KW, Suh KS Liver transplantation for HBsAg-positive recipients using grafts from HBsAg-positive deceased donors. Transpl Int. 2013 Dec;26(12):1173-83.
80. Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS Living-Donor Liver Transplantation Associated with Higher Incidence of Hepatocellular Carcinoma Recurrence Than Deceased-Donor Liver Transplantation. Transplantation. . 2014 Jan 15;97(1):71-7.
81. Kim H, Suh KS, Lee KW, Yi NJ, Hong G, Suh SW, Yoo T, Park MS, Choi Y, Lee HW
Long-Term Outcome of Laparoscopic Versus Open Liver Resection for Hepatocellular Carcinoma: A Case-Controlled Study with Propensity Score Matching. Surg Endosc. 2014 Mar;28(3):950-60.
82. Byun J, Yi NJ, Lee JM, Suh SW, Yoo T, Choi Y, Ko JS, Seo JK, Kim H, Lee HW, Kim HY, Lee KW, Jung SE, Lee SC, Park KW, Suh KS. Long term outcomes of pediatric liver transplantation according to age. J Korean Med Sci. 2014 Mar;29(3):320-7.
83. Choi Y, Yi NJ, Ko JS, Ko JM, Jin US, Kim HS, Lee KH, Cho TJ, Suh SW, Yoo T, Lee KW, Suh KS. Living donor liver transplantation for an infant with osteogenesis imperfecta and intrahepatic cholestasis: report of a case. J Korean Med Sci. 2014 Mar;29(3):441-4.
84. Kim JM, Kwon CH, Yun IJ, Lee KW, Yu HC, Suh KS, Joh JW, Cho BH. A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients. Ann Surg Treat Res. 2014 Apr;86(4):192-8.
85. Lee KW, Yi NJ, Suh KS. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience. Transplantation. 2014 Apr 27;97 Suppl 8:S20-3.
86. Choi Y, Yi NJ, Lee KW, Suh KS. Laparoscopic and minimal incisional donor hepatectomy. Transplantation. 2014 Apr 27;97 Suppl 8:S69-75
87. Chen CL, Cheng YF, Yu CY, Ou HY, Tsang LL, Huang TL, Chen TY, Concejero A, Wang CC, Wang SH, Lin TS, Liu YW, Yang CH, Yong CC, Chiu KW, Jawan B, Eng HL, Chan SC, Sharr WW, Lo CM, Tamura S, Sugawara Y, Kokudo N, Lee KW, Yi NJ, Suh KS, Moon DB, Lee SG, Ahn CS, Huang S, Kim KH, Ha TY, Song GW, Jung DH, Park GC, NamkoongJM, Park HW, Park YH, Park CS, Sung KB, Ko GY, Gwon DI, Kaido T, Ogawa K, FujimotoY, Ito T, Toniyama K, Mori A, Ogura Y, Uemoto S, Yap AQ, Lin YH, Liu CY, Chiang YC, Lin CC, Shin M, Joh JW, Kabiling C, Hu TH, Kang SH, Jung BH, Choi YR. Living donor liver transplantation: the Asian perspective. Transplantation. 2014 Apr 27;97 Suppl 8:S3.
88. Hong G, Yi NJ, Suh SW, Yoo T, Kim H, Park MS, Choi Y, Lee K, Lee KW, Park MH, Suh KS. Preoperative selective desensitization of live donor liver transplant recipients considering the degree of T lymphocyte cross-match titer, model for end-stage liver disease score, and graft liver volume. J Korean Med Sci. 2014 May;29(5):640-7.
89. Kim H, Lee K, Lee KW, Yi NJ, Lee HW, Hong G, Choi Y, You T, Suh SW, Jang JJ, Suh KS. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. Clin Transplant. 2014 May;28(5):521-9.
90. Lee S, Kwon CH, Kim JM, Joh JW, Paik SW, Kim BW, Wang HJ, Lee KW, Suh KS, Lee SK. Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein are important prognostic factors in salvage liver transplant. Liver Transpl. 2014 May 23.
91. Suh SW, Lee KW, Lee JM, You T, Choi Y, Kim H, Lee HW, Lee JM, Yi NJ, Suh KS. Prediction of aggressiveness in early-stage hepatocellular carcinoma for selection of surgical resection. J Hepatol. 2014 Jun;60(6):1219-24.
92. Yang HJ, Lee JH, Lee DH, Yu SJ, Kim YJ, Yoon JH, Kim HC, Lee JM, Chung JW, Yi NJ, Lee KW, Suh KS, Lee HS. Small single-nodule hepatocellular carcinoma: comparison of transarterial chemoembolization, radiofrequency ablation, and hepatic resection by using inverse probability weighting. Radiology. 2014 Jun;271(3):909-18
93. Lee JY, Kim YH, Yi NJ, Kim HS, Lee HS, Lee BK, Kim H, Choi YR, Hong G, Lee KW, Suh KS. Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clin Mol Hepatol. 2014 Jun;20(2):192-203.
94. Suh SW, Lee JM, You T, Choi YR, Yi NJ, Lee KW, Suh KS. Hepatic venous congestion in living donor grafts in liver transplantation: Is there an effect on hepatocellular carcinoma recurrence? Liver Transpl. 2014 Jul;20(7):784-90.
95. Park MS, Yi NJ, Son SY, You T, Suh SW, Choi YR, Kim H, Hong G, Lee KB, Lee KW, Jeong SY, Park KJ, Suh KS, Park JG. Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases. Ann Surg Treat Res. 2014 Jul;87(1):14-21
96. Youn JK, Lee JM, Yi NJ, Choi YR, Suh SW, You T, Lee KW, Jung CW, Lee JW, Bae EJ, Ko JS, Kim WH, Park KW, Suh KS. Pediatric split liver transplantation after Fontan procedure in left isomerism combined with biliary atresia: A case report. Pediatr Transplant. 2014 Sep 27.
97. Kim HY, Yi NJ, Lee JY, Kim JH, Moon MR, Jeong JH, Lee JM, You TS, Suh SW, Park MS, Choi YR, Hong G, Lee HW, Lee KW, and Suh KS Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. Clinical and Molecular Hepatology 2014;20:291-299
98. Garcia A, Yi NJ, Lee KB, Lee JM, Choi YR, Suh SW, You T, Lee KW, Park JD, Kang HJ, Kim JG, Kang EK, Hong G, Suh KS. Fulminant hepatitis linked to dapsone hypersensitivity syndrome requiring urgent living donor liver transplantation: A case report. Pediatr Transplant.2014 Nov;18(7):E240-5.
99. Park MS, Lee KW, Yi NJ, Choi YR, Kim HY, Hong G, Suh KS, David Kwon CH, Joh J Won, and Lee SK. Optimal Tailored Screening Protocol after Living Donor Liver Transp lantation for Hepatocellular Carcinoma. J Korean Med Sci 2014; 2
100. Mori S, Choi Y, Park MS, Kim H, Hong G, Yi NJ, Lee KW, Suh KS. Usefulness of preoper ative C-reactive protein and alpha-fetoprotein levels for prognostication of patients with heap tocellular carcinoma after living donor liver transplantation. Hepatogastroenterology. 2014 N ov-Dec;61(136):2353-8.
101. Suh SW, Lee KW Reply to: "Assessment of long term prognosis at detection of early hepato cellular carcinoma remains unsolved" J Hepatol. 2014 Dec;61(6):1438-9.
102. Lee M, Lee JH, Oh S, Jang Y, Lee W, Lee HJ, Yoo JJ, Choi WM, Cho YY, Cho Y, Lee D H, Lee YB, Yu SJ, Yi NJ, Lee KW, Kim YJ, Yoon JH, Suh KS, Lee HS. CLIF-SOFA scori ng system accurately predicts short-term mortality in acutely decompensated patients with al coholic cirrhosis: a retrospective analysis. Liver Int. 2015 Jan;35(1):46-57
103. Suh SW, Lee KW, Lee JM, Choi Y, Yi NJ, Suh KS. Clinical outcomes of and patient satisfa ction with different incision methods for donor hepatectomy in living donor liver transplantat ion. Liver Transpl. 2015 Jan;21(1):72-8. doi: 10.1002/lt.24033. [Epub ahead of print]
104. Choi WM1, Lee JH, Ahn H, Cho H, Cho YY, Lee M, Yoo JJ, Cho Y, Lee DH, Lee YB, Ch o EJ, Yu SJ, Yi NJ, Lee KW, Kim YJ, Yoon JH, Suh KS, Kim CY, Lee HS. Forns index pre dicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Liver Int. 2015 Jan 2. doi: 10.1111/liv.12776.
105. Suh KS1, Suh SW, Lee JM, Choi Y, Yi NJ, Lee KW. Recent advancements in and views on the donor operation in living donor liver transplantation: A single-center study of 886 patient s over 13 years. Liver Transpl. 2015 Mar;21(3):329-38
106. Son JY, Lee JY, Yi NJ, Lee KW, Suh KS, Kim KG, Lee JM, Han JK, Choi BI. Hepatic Steatos is: Assessment with Acoustic Structure Quantification of US Imaging. Radiology. 2015 Jun 2 9:141779.
107. Yoon JH1, Lee JM, Suh KS, Lee KW, Yi NJ, Lee KB, Han JK, Choi BI. Combined Use of M R Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need fo r Preoperative Liver Biopsy? Radiology. 2015 Mar 12:140908.
108. Suh KS1, Suh SW, Lee JM, Choi Y, Yi NJ, Lee KW. Living donor liver transplantation using a left liver extended to right anterior sector. Transpl Int. 2015 Mar 16.
109. Mori S1, Park MS, Kim H, Choi Y, Hong G, Yi NJ, Lee KW, Suh KS. Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation. Int Surg. 2015 Mar;100( 3):524-30.
110. Choi Y1, Lee KW2, Kim H3, Suh SW3, Hong G3, Lee HW3, Yi NJ3, Suh KS3. Identificatio n of a safe and adequate division point of the left-sided bile duct with magnetic resonance chol angiography during donor left lateral sectionectomy. Surgery. 2015 Apr;157(4):785-91.
111. Kim H, Lee KW, Yi NJ, Lee HW, Choi Y, Suh SW, Jeong J, Suh KS. Outcome and technical a spects of liver retransplantation: analysis of 25-year experience in a single major center. Trans plant Proc. 2015 Apr;47(3):727-9.
112. Lee YB, Lee DH, Cho Y, Yu SJ, Lee JH, Yoon JH, Lee HS, Kim HC, Yi NJ, Lee KW, Suh K S, Chung JW, Kim YJ. Comparison of transarterial chemoembolization and hepatic resection for large solitary hepatocellular carcinoma: a propensity score analysis. J Vasc Interv Radiol. 2015 May;26(5):651-9.
113. Choi Y, Lee JM, Yi NJ, Kim H, Park MS, Hong G, Yoo T, Suh SW, Lee HW, Lee KW, Suh KS.
Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging. Ann Sur g Treat Res. 2015 Jul;89(1):37-42.
114. Yang J, Ryu H, Han M, Kim H, Hwang YH, Chung JW, Yi NJ, Lee KW, Suh KS, Ahn C. Co mparison of volume-reductive therapies for massive polycystic liver disease in autosomal dom inant polycystic kidney disease. Hepatol Res. 2015 Jul 20.
115. Choi JW, Jae HJ, Kim HC, Yi NJ, Lee KW, Suh KS, Chung JW. Long-term outcome of endov ascular intervention in hepatic venous outflow obstruction following pediatric liver transplant ation. Liver Transpl. 2015 Jul 22.
116. Yoon JH, Lee JM, Suh KS, Lee KW, Yi NJ, Lee KB, Han JK, Choi BI. Combined Use of MR Fat Quantification and MR Elastography in Living Liver Donors: Can It Reduce the Need for Preoperative Liver Biopsy? Radiology. 2015 Aug;276(2):453-64.
117. Choi WM, Lee JH, Ahn H, Cho H, Cho YY, Lee M, Yoo JJ, Cho Y, Lee DH, Lee YB, Cho EJ, Yu SJ, Yi NJ, Lee KW, Kim YJ, Yoon JH, Suh KS, Kim CY, Lee HS. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection. Liver Int. 2015 Aug;35(8):1992-2000.
118. Choi JW, Jae HJ, Kim HC, Yi NJ, Lee KW, Suh KS, Chung JW. Long-term outcome of endovascular intervention in hepatic venous outflow obstruction following pediatric liver transplantation. Liver Transpl. 2015 Sep;21(9):1219-26.
119. Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ. Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma. BMC Cancer. 2015 Oct 16;15:721
120. Kim H, Lee KW, Yi NJ, Lee HW, Choi Y, Suh SW, Jeong J, Suh KS. Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation. J Korean Med Sci. 2015 Nov;30(11):1577-83.
121. Jang YR, Lee KW, Kim H, Lee JM, Yi NJ, Suh KS. Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma. Korean J Hepatobiliary Pancreat Surg. 2015 Nov;19(4):167-72.
122. Hong K, Kim H, Lee JM, Lee KW, Yi NJ, Lee HW, Choi Y, Suh SW, Hong SK, Yoon KC, Kim HS, Suh KS. Fatigue and related factors after liver transplantation. Korean J Hepatobiliary Pancreat Surg. 2015 Nov;19(4):149-53.
123. Lee JH, Lee Y, Lee M, Heo MK, Song JS, Kim KH, Lee H, Yi NJ, Lee KW, Suh KS, Bae YS, Kim YJ. A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Br J Cancer. 2015 Dec 22;113(12):1666-76.
124. Navarro Burgos JB, Lee KW, Shin YC, Lee DS, Lee KB, Yi NJ, Suh KS. Inexplicable Outcome of Early Appearance of Hepatocellular Carcinoma in the Allograft After Deceased Donor Liver Transplantation: A Case Report. Transplant Proc. 2015 Dec;47(10):3012-5.
125. Son JY, Lee JY, Yi NJ, Lee KW, Suh KS, Kim KG, Lee JM, Han JK, Choi BI. Hepatic Steatosis: Assessment with Acoustic Structure Quantification of US Imaging. Radiology. 2016 Jan;278(1):257-64.
126. Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CH, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG. Outcomes for patients with HCV after liver transplantation in Korea: a multicenter study. Ann Surg Treat Res. 2016 Jan;90(1):36-42.
127. Yang J, Ryu H, Han M, Kim H, Hwang YH, Chung JW, Yi NJ, Lee KW, Suh KS, Ahn C. Comparison of volume-reductive therapies for massive polycystic liver disease in autosomal dominant polycystic kidney disease. Hepatol Res. 2016 Feb;46(2):183-91
128. Ah YM, Lee JY, Moon MR, Cho YS, Kim HS, Yi NJ, Lee KW, Suh KS. Clinical and economic evaluation of pharmacists' contribution to patient care on a multi-disciplinary liver transplant team. Int J Clin Pharmacol Ther. 2016 Feb;54(2):102-9.
129. Choi Y, Yi NJ, Ko JS, Moon JS, Suh SW, Lee JM, Jeong JH, Kim H, Lee HW, Lee KW, Suh KS. Reappraisal of the Role of Portacaval Shunting in the Growth of Patients With Glycogen Storage Disease Type I in the Era of Liver Transplantation. Transplantation. 2016 Mar;100(3):585-92.
130. Hong G, Suh KS, Suh SW, Yoo T, Kim H, Park MS, Choi Y, Paeng JC, Yi NJ, Lee KW. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation. J Hepatol. 2016 Apr;64(4):852-9.
131. Lee KW, Seo YD, Oh SC, Suh SW, Jeong J, Kim H, Yi NJ, Suh KS. What is the best immunosuppressant combination in terms of antitumor effect in hepatocellular carcinoma? Hepatol Res. 2016 May;46(6):593-600.
132. Lee JH, Cho Y, Kim HY, Cho EJ, Lee DH, Yu SJ, Lee JW, Yi NJ, Lee KW, Kim SH, Kim JM, Joh JW, Teperman LW, Park JS, Kim YJ, Suh KS, Yoon JH. Serum Tumor Markers Provide Refined Prognostication in Selecting Liver Transplantation Candidate for Hepatocellular Carcinoma Patients Beyond the Milan Criteria. Ann Surg. 2016 May;263(5):842-50.
133. Yi NJ, Lee JM, Kim H, Choi Y, Lee HW, Kim HY, Jin US, Ko JS, Moon JS, Jung CW, Lee KW, Suh KS. Simple ellipsoid reconstruction technique for a hypoplastic portal vein during pediatric liver transplantation. Liver Transpl. 2016 Jun;22(6):854-8
134. Lee ES, Han JK, Baek JH, Suh SW, Joo I, Yi NJ, Lee KW, Suh KS. Long-Term Efficacy of Percutaneous Internal Plastic Stent Placement for Non-anastomotic Biliary Stenosis After Liver Transplantation. Cardiovasc Intervent Radiol. 2016 Jun;39(6):909-15.
135. Yoo T, Lee KW, Yi NJ, Choi YR, Kim H, Suh SW, Jeong JH, Lee JM, Suh KS. Peri-Transplant Change in AFP Level: A Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation. J Korean Med Sci. 2016 Jul;31(7):1049-54.
136. Chang W, Lee JM, Yoon JH, Han JK, Choi BI, Yoon JH, Lee KB, Lee KW, Yi NJ, Suh KS. Liver Fibrosis Staging with MR Elastography: Comparison of Diagnostic Performance between Patients with Chronic Hepatitis B and Those with Other Etiologic Causes. Radiology. 2016 Jul;280(1):88-97.
137. Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CD, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG. Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection. Clin Mol Hepatol. 2016 Sep;22(3):366-371.
138. Suh KS, Hong SK, Yi NJ, Lee KW, Kim HS, Yoon KC, Kim H. Pure 3-dimensional laparoscopic extended right hepatectomy in a living donor. Liver Transpl. 2016 Oct;22(10):1431-6.
139. Chu HH, Yi NJ, Kim HC, Lee KW, Suh KS, Jae HJ, Chung JW. Longterm outcomes of stent placement for hepatic venous outflow obstruction in adult liver transplantation recipients. Liver Transpl. 2016 Nov;22(11):1554-1561.
140. Suh SW, Lee KW, Jeong J, Kim H, Yi NJ, Suh KS. Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients. J Korean Med Sci. 2016 Nov;31(11):1711-1716.
141. Hong SK, Lee KW, Kim HS, Yoon KC, Yi NJ, Suh KS. Living donor liver transplantation for hepatocellular carcinoma in Seoul National University. Hepatobiliary Surg Nutr. 2016 Dec;5(6):453-460.
142. Hong SK, Lee KW, Kim HS, Yoon KC, Ahn SW, Choi JY, Kim H, Yi NJ, Suh KS. Optimal bile duct division using real-time indocyanine green near-infrared fluorescence cholangiography during laparoscopic donor hepatectomy. Liver Transpl. 2016 Dec 9.
143. Suh KS, Kim HS, Yi NJ, Lee KW, Hong SK, Yoon KC, Nugroho A, Kim H. Living donor liver transplantation using a right anterior section of the liver. Liver Transpl. 2016 Dec 27.
144. Lee KW, Suh SW, Choi Y, Jeong J, Yi NJ, Kim H, Yoon KC, Hong SK, Kim HS, Lee KB, Suh KS. Macrovascular invasion is not an absolute contraindication for living donor liver transplantation. Liver Transpl. 2017 Jan;23(1):19-27.
145. Lee H, Yoon JH, Kim H, Yi NJ, Hong SK, Yoon KC, Kim HS, Ahn SW, Choi JY, Choi Y, Lee HW, Yi JY, Lee KB, Lee KW, Suh KS. False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients. J Korean Med Sci. 2017 Feb;32(2):315-320.
146. Nugroho A, Kim OK, Lee KW, Song S, Kim H, Hong SK, Yoon KC, Kim HS, Choi Y, Lee HW, Yi NJ, Suh KS. Evaluation of donor workups and exclusions in a single center experience of living donor liver transplantation. Liver Transpl. 2017 Mar 14
147. Joo I, Lee JY, Lee DH, Jeon JH, Kim H, Yi NJ, Lee KW, Suh KS. Contrast-Enhanced Ultrasound Using Perfluorobutane-Containing Microbubbles in the Assessment of Liver Allograft Damage: An Exploratory Prospective Study. Ultrasound Med Biol. 2017 Mar;43(3):621-628.
148. Lim KH, Park ES, Kim DH, Cho KC, Kim KP, Park YK, Ahn SH, Park SH, Kim KH, Kim CW, Kang HS, Lee AR, Park S, Sim H, Won J, Seok K, You JS, Lee JH, Yi NJ, Lee KW, Suh KS, Seong BL, Kim KH. Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of TRIM22. Gut. 2017 Mar 23.
149. Lee DH, Lee JM, Yi NJ, Lee KW, Suh KS, Lee JH, Lee KB, Han JK. Hepatic stiffness measurement by using MR elastography: prognostic values after hepatic resection for hepatocellular carcinoma. Eur Radiol. 2017 Apr;27(4):1713-1721.
150. Kang HJ, Lee JM, Yoon JH, Joo I, Chang W, Suh KS, Lee KW, Yi NJ, Han JK, Additional values of high-resolution gadoxetic acid-enhanced MR cholangiography for evaluating the biliary anatomy of living liver donors: Comparison with T2 -weighted MR cholangiography and conventional gadoxetic acid-enhanced MR cholangiography., J Magn Reson Imaging. 2017 Apr 11
151. Mussin N, Sumo M, Lee KW, Choi Y, Choi JY, Ahn SW, Yoon KC, Kim HS, Hong SK, Yi NJ, Suh KS. The correlation between preoperative volumetry and real graft weight: comparison of two volumetry programs. Ann Surg Treat Res. 2017 Apr;92(4):214-220
152. Pure laparoscopic right hepatectomy in a patient with situs inversus totalis: A case report. Hong SK, Suh KS, Kim HS, Ahn SW, Yoon KC, Kim H, Yi NJ, Lee KW. Medicine (Baltimore). 2017 Aug;96(34):e7910.
153. Pure laparoscopic living donor hepatectomy: Focus on 55 donors undergoing right hepatectomy. Suh KS, Hong SK, Lee KW, Yi NJ, Kim HS, Ahn SW, Yoon KC, Choi JY, Oh D, Kim H. Am J Transplant. 2017 Aug.
154. Sirolimus and Metformin Synergistically Inhibits Colon Cancer In Vitro and In Vivo. Mussin N, Oh SC, Lee KW, Park MY, Seo S, Yi NJ, Kim H, Yoon KC, Ahn SW, Kim HS, Hong SK, Oh DK, Suh KS. J Korean Med Sci. 2017 Sep;32(9):1385-1395. doi: 10.3346/jkms.2017.32.9.1385.
155. Efficacy and Safety of Generic Mycophenolate Mofetil (My-rept) 500-Milligram Tablets in Primary Liver Transplant Recipients. Hong SK, Lee KW, Yoon KC, Kim HS, Kim H, Yi NJ, Suh KS.Transplant Proc. 2017 Jul - Aug;49(6):1402-1408. doi: 10.1016/j.transproceed.2017.02.056.item 28718984.
156. Effect of PNPLA3 I148M polymorphism on histologically proven non-alcoholic fatty liver disease in liver transplant recipients. Kim H, Lee KW, Lee K, Seo S, Park MY, Ahn SW, Hong SK, Yoon KC, Kim HS, Choi Y, Lee HW, Yi NJ, Suh KS. Hepatol Res. 2017 Jul 18. doi: 10.1111/hepr.12940. [Epub ahead of print]
157. Delayed transplantation may affect intellectual ability in children. Lee JM, Jung YK, Bae JH, Yoon SA, Kim JH, Choi Y, Kim H, Lee KW, Ahn HY, Kim JW, Shin MS, Suh KS, Ha IS, Cheong HI, Kang HG, Yi NJ. Pediatr Int. 2017 Jul 17. doi: 10.1111/ped.13369. [Epub ahead of print]
158. Split liver transplantation for retroperitoneal immature teratoma masquerading as hepatoblastoma. Oh D, Yi NJ, Song S, Kim OK, Hong SK, Yoon KC, Ahn SW, Kim HS, Kim H, Kim HY, Kang HJ, Lee M, Lee KB, Lee KW, Suh KS. Pediatr Transplant. 2017 Jul 16. doi: 10.1111/petr.13025. [Epub ahead of print]
159. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas. Lee K, Lee KB, Jung HY, Yi NJ, Lee KW, Suh KS, Jang JJ. BMC Cancer. 2017 Jun 23;17(1):441. doi: 10.1186/s12885-017-3431-1.
160. Surgical Techniques of Allogeneic Liver Transplantation in a Nonhuman Primate Model. Kim H, Kim H, Lee JI, Ahn SW, Hong SK, Yoon KC, Kim HS, Choi JY, Oh D, Yi NJ, Yang J, Lee KW, Suh KS.Transplant Proc. 2017 Jun;49(5):1150-1152. doi: 10.1016/j.transproceed.2017.03.024.
161. Usefulness of PIVKA-II After Living-donor Liver Transplantation for Hepatocellular Carcinoma. Park MS, Lee KW, Kim H, Choi YR, Hong G, Yi NJ, Suh KS. Transplant Proc. 2017 Jun;49(5):1109-1113. doi: 10.1016/j.transproceed.2017.03.017.
162. Primary Living-donor Liver Transplantation Is Not the Optimal Treatment Choice in Patients With Early Hepatocellular Carcinoma With Poor Tumor Biology. Park MS, Lee KW, Kim H, Choi YR, Hong G, Yi NJ, Suh KS. Transplant Proc. 2017 Jun;49(5):1103-1108. doi: 10.1016/j.transproceed.2017.03.016.
163. Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria. Cho Y, Lee JH, Lee DH, Cho EJ, Yu SJ, Yi NJ, Lee KW, Kim YJ, Yoon JH, Suh KS. Oncotarget. 2017 Jul 18;8(29):47555-47564. doi: 10.18632/oncotarget.17733.
164. Tips and pitfalls in direct ligation of large spontaneous splenorenal shunt during liver transplantation. Kim H, Yoon KC, Lee KW, Yi NJ, Lee HW, Choi Y, Oh D, Kim HS, Hong SK, Ahn SW, Suh KS. Liver Transpl. 2017 Jul;23(7):899-906. doi: 10.1002/lt.24783.
165. Survival benefit of liver resection for Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma. Kim H, Ahn SW, Hong SK, Yoon KC, Kim HS, Choi YR, Lee HW, Yi NJ, Lee KW, Suh KS; Korean Liver Cancer Association. Br J Surg. 2017 Jul;104(8):1045-1052. doi: 10.1002/bjs.10541. Epub 2017 May 8.
166. Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation. Hong SK, Yi NJ, Kim HS, Ahn SW, Yoon KC, Kim H, Lee KW, Suh KS. J Korean Med Sci. 2017 Jun;32(6):919-925. doi: 10.3346/jkms.2017.32.6.919.
167. Pure 3D laparoscopic living donor right hemihepatectomy in a donor with separate right posterior and right anterior hepatic ducts and portal veins. Hong SK, Suh KS, Kim HS, Yoon KC, Ahn SW, Oh D, Kim H, Yi NJ, Lee KW. Surg Endosc. 2017 Apr 14. doi: 10.1007/s00464-017-5535-8. [Epub ahead of print]
168. Additional values of high-resolution gadoxetic acid-enhanced MR cholangiography for evaluating the biliary anatomy of living liver donors: Comparison with T2 -weighted MR cholangiography and conventional gadoxetic acid-enhanced MR cholangiography. Kang HJ, Lee JM, Yoon JH, Joo I, Chang W, Suh KS, Lee KW, Yi NJ, Han JK. J Magn Reson Imaging. 2017 Apr 11. doi: 10.1002/jmri.25725. [Epub ahead of print]
169. Suppression of interferon-mediated anti-HBV response by single CpG methylation in the 5'-UTR of TRIM22. Lim KH, Park ES, Kim DH, Cho KC, Kim KP, Park YK, Ahn SH, Park SH, Kim KH, Kim CW, Kang HS, Lee AR, Park S, Sim H, Won J, Seok K, You JS, Lee JH, Yi NJ, Lee KW, Suh KS, Seong BL, Kim KH. Gut. 2017 Mar 23. pii: gutjnl-2016-312742. doi: 10.1136/gutjnl-2016-312742. [Epub ahead of print]
170. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer.
Woo HG, Choi JH, Yoon S, Jee BA, Cho EJ, Lee JH, Yu SJ, Yoon JH, Yi NJ, Lee KW, Suh KS, Kim YJ. Nat Commun. 2017 Oct 10;8(1):839.
171. Memory T cells are significantly increased in rejected liver allografts of rhesus monkeys.
Kim H, Kim H, Lee SK, Jin XL, Kim TJ, Park C, Lee JI, Kim HS, Hong SK, Yoon KC, Ahn SW, Lee KB, Yi NJ, Yang J, Lee KW, Hawthorne WJ, Suh KS. Liver Transpl. 2018 Feb;24(2):256-268
172. Increased survival in hepatitis c patients who underwent living donor liver transplant: a case-control study with propensity score matching. Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CHD, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG. Ann Surg Treat Res. 2017 Dec;93(6):293-299
173. Pretransplantation fetal-maternal microchimerism in pediatric liver transplantation from mother. Yi NJ, Park MS, Song EY, Ahn HY, Byun J, Kim H, Hong SK, Yoon K, Kim HS, Ahn SW, Lee HW, Choi Y, Lee KW, Suh KS, Park MH. World J Gastroenterol. 2017 Dec 7;23(45):8017-8026
174. A Model for Adaptive Decision Making of "Ablate-and-Wait" Versus Transplantation in Patients With Hepatocellular Carcinoma. Kim HY, Kim W, Jung YJ, Lee JH, Yu SJ, Kim YJ, Yoon JH, Lee HW, Kim H, Yi NJ, Lee KW, Suh KS. J Clin Gastroenterol. 2018 Jan 19
175. Pediatric Living Donor Liver Transplantation Using a Monosegment Procured by Pure 3D Laparoscopic Left Lateral Sectionectomy and In situ Reduction. Hong SK, Suh KS, Kim HS, Yoon KC, Ahn SW, Kim H, Yi NJ, Lee KW. J Gastrointest Surg. 2018 Jun;22(6):1135-1136
176. Emergency department visits and unanticipated readmissions after liver transplantation: A retrospective observational study. Oh SY, Lee JM, Lee H, Jung CW, Yi NJ, Lee KW, Suh KS, Ryu HG.
Sci Rep. 2018 Mar 6;8(1):4084
177. Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma. Kim JM, Yi NJ, Kwon CHD, Lee KW, Suh KS, Joh JW. Ann Surg Treat Res. 2018 Mar;94(3):129-134
178. Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation. Kim H, Yi NJ, Song EY, Lee K, Lee KW, Lee HW, Ahn HY, Yoon KC, Hong SK, Suh KS. Clin Transplant. 2018 May;32(5):e13244.
179. Initial experience with purely laparoscopic living-donor right hepatectomy. Hong SK, Lee KW, Choi Y, Kim HS, Ahn SW, Yoon KC, Kim H, Yi NJ, Suh KS. Br J Surg. 2018 May;105(6):751-759.
180. One Hundred and Fifteen Cases of Pure Laparoscopic Living Donor Right Hepatectomy at a Single Center. Lee KW, Hong SK, Suh KS, Kim HS, Ahn SW, Yoon KC, Lee JM, Cho JH, Kim H, Yi NJ.
Transplantation. 2018 Apr 21.
181. Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification. Lee M, Chang Y, Oh S, Cho YY, Jung DE, Kim HH, Nam JY, Cho H, Cho EJ, Lee JH, Yu SJ, Yi NJ, Lee KW, Lee DH, Lee JM, Yoon JH, Suh KS, Kim YJ. Gut Liver. 2018 Jun 22
182. Survival Outcomes in Split Compared to Whole Liver Transplantation. Yoon KC, Song S, Jwa EK, Lee S, Kim JM, Kim OK, Hong SK, Yi NJ, Lee KW, Kim MS, Hwang S, Suh KS, Lee SK. Liver Transpl. 2018 May 10.
183. The rate of hepatic artery complications is higher in pediatric liver transplant recipients with metabolic liver diseases than with biliary atresia. Hong SK, Yi NJ, Chang H, Ahn SW, Kim HS, Yoon KC, Kim H, Park SO, Jin US, Minn KW, Lee KW, Suh KS. J Pediatr Surg. 2018 Apr 27.
184. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion. Lee JM, Lee KW, Hong SK, Yoon KC, Cho JH, Yi NJ, Suh KS. Ann Surg Oncol. 2018 Jul 17.
Book Chapters:
1. S.K. Lee and K.W. Lee. Basic immunology in tissue engineering. In: Tissue engineering and regenerative medicine. 1st ed. Kunja press, 2002: 165-177.
2. Y.J Lee and K.W Lee. Massive Hepatectomy. In: Hepato-Biliary-Pancreatic Surgery 3rd edition. Medrang, 2013: 545-557
3. K.W Lee. Patient Management after Liver Transplantation. In: Hepato-Biliary-Pancreatic Surgery 3rd edition. Medrang, 2013: 615-62
Grants
Previous grants
1. The clinical significance of hepatocytes-pancreatic islet cell spheroids. Funded by SBRI(Samsung Biomedical Research Instutute). 2001. C-A2-219-1. \2,500,000
2. The function of capsulated hepatocytes-islet cell sheroids. Funded by SBRI. 2002. C-A2-219-2. \5,000,000
3. The clinical significance of hepatocytes-islet cell spheroid with sustained released VEGF capsule. Funded by SBRI. 2003. C-A2-312-1. \7,000,000
4. Clinical application of hepatocytes transplantation. Funded by SBRI. 2004. C-A4-221-1. \21,000,000
5. Clinical application of hepatocytes transplantation. Funded by SBRI. 2005. C-A4-221-2. \32,000,000
6. The development of sustained releasing cellular growth factor model for cell transplantation. Funded by Korea Research Fund (KRF). 2002.7.1/2003.6.30. \13,000,000
7. Gene delivery into the liver graft using virus vector. Funded by NCC. \70,000,000
8. Gene delivery into the liver graft using virus vector. Funded by SNUH. \10,000,000
9. Chemosensitivity according to immunosuppressants. Funded by SNU R&DB Foundation. 2011.3/2013.2 \ 80,000,000
10. The study of the effect of immunosuppressants on ischemic bile duct injury after liver transplantation. Funded by SNU R&DB Foundation. 2011.11/2013.10 \ 69,000,000
11. Chemosensitivity according to immunosuppressants in animal tumor model. Funded by SNU R&DB Foundation. 2013.4/2015.3 \ 80,000,000
12. The study of the effect of various immunosuppressants on ischemic bile duct injury in animal model. Funded by SNU R&DB Foundation. 2013.10/2015.9 \ 100,050,000
13. The study of mechanism of endocytosis of IV Hepabig. Funded by Green Cross Crop. 2014.3-2016.1 \350,000,000
14. The clinical outcome according to the polymorphism in Donor and Recipient in LDLT. Funded by Yuhan Crop. 2014.4-2016.4 \50,000,000
15. The significance of Livin protein in selecting optimal candidate for sorafenib treatment in HCC. Funded by Seoul National University Hospital 2014.6-2015.5 \ 30,000,000
Current grants
1. A randomized phase II, trial with sirolimus-containing versus mTOR-inhibitor free immunosuppression in patients undergoing living donor liver transplantation for hepatocellular carcinoma exceeding Milan criteria. Funded by Pfizer Ltd., 2010.5-2017.6 \135,811,528
2. 간 이식술 환자를 대상으로 면역억제제 3제 요법 시 코르티코스테로이드 사용기간에 따른이식술 후 새로 발병한 당뇨병(NODAT; New-onset diabetes after transplantation)의 발병률 및 안전성？유효성 평가를 위한 다기관 공동, 공개, 무작위배정, 연구자주도임상시험.삼성서울병원 (The incidence of NODAT according to the steroid withdrawal time) 2014.4-2017.12 \51,400,000
3. Outcome after living donor liver transplantation for hepatocellular carcinoma with macro-vascular invasion. Funded by SNU. 2015.05-2017.04\10,000,000
4. Practice liver transplant surgery sing microsurgical techniques. (재)서울대학교의과대학교육연구재단 2015.08-2018.07\10,000,000
5. The effect of Metformin and various immunosuppressants on breast cancer, gastric cancer and colon cancer after liver transplantation. (재)서울대학교의과대학교육연구재단 2015.12-2017.06\29,659,530
6. 안정적인 간 이식 환자를 대상으로 Tacrolimus (bid)에서 Advagraf® (qd)로 전환 시 CYP3A5 polymorphism이 간 기능 이상 발생 및 Trough level 변화에 미치는 영향에 관한 연구. Funded by Astellas Pharma Korea, Inc. 2016.03-2017.11 \425,000,000
7. Tacrolimus가 간세포암 세포주에서의 EMT 유발에 대한 연구. Funded by Chong Kun Dang pharmaceutical Crop. 2016.04-2018.03 \80,000,000
Presentation activities (for current 2 years only)
1. The 2nd MYONGJI International Liver Symposium, “ABO-incompatible vs ABO-incompatible vs ABO-compatible LDLT; immunosuppression, complications and outcomes”, 2017.09.08
2. 53rdAnnual Meeting of Liver Canner Study Group of Japan @ Tokyo, “Reappraisal of the Milano criteria based on Evidence and Consensus”, 2017.07.06
3. Bundang SGR, Overseas expansion of Korean medical care, 2017.06.28
4. The Liver Week 2017, “Tips and Pitfalls of Various Types of Stapler in Laparoscopic Hepatectomy”, 2017.06.23
5. The Liver Week 2017, “Primary vs. Salvage Liver Transplantation after Resection of HCC”, 2017.06.22-24
6. Joint Congress of The 6th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association & The 29th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery, “Changes of Hepatitis B surface antigen after hepatitis B immunoglobulin injection during liver transplantation using hepatitis B virus graft”, “Hepatitis B virus immunoglobulin is internalized in hepatocytes via endocytosis and induce auto-phagosome”, “Neat and quick pure 3D laparoscopic donor right hepatectomy using modified hanging maneuver”, “Comparing the different effects of chemotherapy combinations with immunosuppression on three HCC tumor cell lines”, “Should a Split Procedure Always be Considered in DDLT-No”, “Laparoscopic Right Anterior Sectionectomy”, “Tips in Donor Hepatectomy”, 2017.06.08-09
7. Liver Transplant Symposium, 2017.06.03
8. ILTS, “Sirlimus Prolonged Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria; Outcome of a Multicenter Prospective Randomized Control Phase II Trial”, @Praha, 2017.05.27
9. The 13th Spring Symposium, “long-term outcome of LT and cause of long-term mortality in Korea (multicenter study)”, “Utility of urine biomarker for obstacle predicted of kidney functions after liver tranplant” @Woolsan Science University, 2017.05.13
10. EVEROSIA; Asia cross country ABM, “Clinical tools to select HCC patients for transplantation”, 2017.04.21
11. HBP Surgery Week 2017, “Treatment options for BS after LT”, @JEJU, 2017.04.01
12. 2017 Celebrating Symposium for the 100th Pure Laparoscopic Living Donor Hepatectomy, “Outcome of 100 pure laparoscopic donor hepatectomies”, 2017.03.30
13. 2017 Liver Forum, 2017.03.25
14. Asia Pacific Transplant Caucus 2017, “New-generation DAA in the Real World, Differences among countries-insurance policies, guidelines, outcomes, medical situation, etc., DAA data accumulated, expect to be different next year”, 2017.03.10-11
15. Myanmar-Korea Organ Transplantation Seminar, “Art of Liver Transplantation (Video+Lecture)” @University of Medicine, Yangon, 2017.02.22-24
16. Hepatobiliary & Pancreatic Surgery Course 2017 - 3D Laparoscopic HBP Symposium & Workshop, 2017.01.07
16. XIII International Conference of Society of Surgeon's of Nepal, 2016.12.23-24
17. New Horizons of Hepatology – 2016, Astana, 2016.12.16-17
18. CME Meeting (Transplant Symposium, Taiwan), “Outcomes for patients with HCV after liver transplantation in Korea”, 2016.11.12-13
19. DDLT/KT pig workshop, SNUH Biomedical Research Institute, 2016.10.30
20. ATW(Autumn Transplant Symposium), “Vitamin D receptor polymorphism and biliary complications in living donor liver transplantation & Korean experience 2”, Incheon, Korea, 2016.10.27-29
21. ICS Kyoto 2016, 40th world congress of the international College of surgeons, Kyoto, 2016.10-23-26
22. Republican scientific-practical conference, 2016.10.18-22
23. 21st Biennial Surgeons' Conference, “Various recipient hepatectomy applying high hilar dissection technique”, @Hotel Shwe Pyi Thar, 2016.10.7-9
24. 6th Symposium of Kazakhstan Association of Endoscopic Surgeons, “CCV”, @Kazakhstan, 2016.10.03-05
25. Shenzhen Surgical Forum, Hong Kong, 2016.09.25
26. Hong Kong Surgical Forum, 2016.09.24
27. CLBS Symposium, New Delhi, India, 2016.09.14-18
28. 2016 Korea-Uzbekistan Promotion of Korea Medical Science, @Uzbekistan, 2016.09.05-07
29. IASGO 2016, “HCC with Child A -LT First”, Sheraton Grande Walkerhill Hotel, Seoul, Korea1 2016.09.08-10
30. Severance Hospital Commemoration Symposium of Kidney Transplant breaking 400 tunes, 2016.09.09
31. ISTS 2016, Jeon-buk University, 2016.09.02-03
32. Mongolian International Joint Symposium, @Ulaanbaatar, Mongolia, 2016.08.26-28
33. The 34th Japanese Liver Transplantation Society, Incheon, Korea, 2016.06.16-18
34. Liver Week 2016, “Macro-Vascular Invasion of Hepatocellular Carcinoma Is Not an Absolute Contraindication for Living Donor Liver Transplantatio, @Grand Hyatt Incheon, 2016.06.16-18
35. Medical Korea 2016, @China, 2016.06.14-16
36. Medical Korea 2016, @Khabarovsk, Russia, 2016.06.02-04
37. ILTS 2016, “Various types of donor incision in living donor liver transplantation” and “Hepatitis B virus immunoglobulin is internalized in hepatocytes via endocytosis and induce auto-phagosome”, @Coex, Seoul, 2016.05.04-07
38. 1st LDLT Surgical Skill Workshop, “Selection of suture material and stapling device” and “Hands-on & on-site panel discussion”, SNUH, Korea, 2016.05.07
39. Gilead HCV symposium at ILTS Congress, 2016.05.05
40. ILTS2016 Live Demonstration, 2016.05.03
41. The Korean Medical Tourism Association Inaugural Assembly & Symposium, 2016.04.28
42. IHPBA 2016, “Outcome of rituximab-based desensitization protocol without local infusion therapy for AGBO incompatible LDLT at single center experience”, @Brazil, 2016.04.20-23
43. The 44th Spring Heapatopancreaticobiliary Symposium, “mTOR inhibitors in liver transplantation for HCC”, 2016.04.01-02
44. Expert Meeting in Liver(EML)2016, Busan, South Korea, 2016.03.19-20
45. The 5th Hapatic Resection Workshop, 2016.02.28
46. The 20th Training Lecture of SNUH, “Room for living donor liver transplantation”, 2016.02.27
47. The 8th Winter Symposium of SNUH, 2016.02.19-20
19th September, 2017
Kwang-Woong Lee
[pic]
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.